Global Health Limited (MEDANTA)

1,162.45

INR
+23.85(+2.09%)
As of December 4, 2024 10:00:00 AM

Global Health Limited Share Price Information

24 hour Low and High

Low: 1100.05
High: 1141.35

All time High

8073.94

Price Change 1h

+₹62.40 +5.67%

Price Change 1d

+₹62.40 +5.67%

Price Change 1w

+₹90.50 +8.44%

Global Health Limited Market Information

Exchange

NSE

Market Cap

29703.98 Cr

About Global Health Limited Share

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Sector

Healthcare

Medical Care Facilities

Employees

about

9052

CEO

Mr. Pankaj Prakash Sahni

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Aegis Logistics, Laurus Labs, Piramal Ent & Medanta: What Axis Securities says on these 4 stocks
  • Global Health Q2 Results: Medanta operator posts 5% rise in net profit YoY at Rs 131 crore
  • Q2FY25: Global Health Limited reports rise in profit by 4.5 percent to Rs. 130.82 crore Y-o-Y
  • Following recent decline, Global Health Limited's (NSE:MEDANTA) top shareholder Top Key Executive Naresh Trehan sees holdings value drop by 3.1%
  • Global Health Share Price

FAQs

Global Health Limited (MEDANTA)

1,162.45

INR
+23.85(+2.09%)
As of December 4, 2024 10:00:00 AM

Global Health Limited Share Price Information

24 hour Low and High

Low: 1100.05
High: 1141.35

All time High

8073.94

Price Change 1h

+₹62.40 +5.67%

Price Change 1d

+₹62.40 +5.67%

Price Change 1w

+₹90.50 +8.44%

Global Health Limited Market Information

Exchange

NSE

Market Cap

29703.98 Cr

About Global Health Limited Share

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Sector

Healthcare

Medical Care Facilities

Employees

about

9052

CEO

Mr. Pankaj Prakash Sahni

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Aegis Logistics, Laurus Labs, Piramal Ent & Medanta: What Axis Securities says on these 4 stocks
  • Global Health Q2 Results: Medanta operator posts 5% rise in net profit YoY at Rs 131 crore
  • Q2FY25: Global Health Limited reports rise in profit by 4.5 percent to Rs. 130.82 crore Y-o-Y
  • Following recent decline, Global Health Limited's (NSE:MEDANTA) top shareholder Top Key Executive Naresh Trehan sees holdings value drop by 3.1%
  • Global Health Share Price

FAQs